35th Annual Meeting of the EBMT

Home

About us

Pipeline

Partners

Investor relations

Newsroom

Careers

Contact

Press Releases Events Newsletter Sign-Up Contact

EBMT

Principal Investigators of Kiadis Pharma have presented at the 35th Annual Meeting of the European Group for Blood and Marrow Transplantation in Göteborg on its lead product ATIR™

Satellite Symposium: “Improving the outcomes of matched and mismatched transplants by selective allodepletion of T-cells”

PDF brochure with abstracts of the satellite symposium

Kiadis Pharma receives IND approval from FDA to start pivotal clinical trial with ATIR™ Jul 8th 2010

Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US... read more

(NL version)

Kiadis Pharma Provides ATIR™ Update: Two Year Follow-Up Data Show No Cases of Transplant Related Mortality - FDA grants ATIR™ Orphan Drug Status as a Medicinal Cell Based Therapy to Reduce Transplant Related Mortality Apr 28th 2010

Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.
ATIR™ continues to show... read more

(NL version)

Entrada 231-234
1096 EG Amsterdam
The Netherlands
t +31 (0)20 314 02 50
f +31 (0)20 314 02 51